Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions.
Kroeze E, Kleisman MM, Hagelaar R, Bladergroen RS, Kester LA, Scheijde-Vermeulen MA, van Dijk F, Meijerink JPP, Kuiper RP, Loeffen JLC. Kroeze E, et al. Among authors: scheijde vermeulen ma. Blood Neoplasia. 2024 Jun 27;1(3):100029. doi: 10.1016/j.bneo.2024.100029. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40548198 Free PMC article. No abstract available.
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Kemps PG, Woei-A-Jin FJSH, Schöffski P, Tousseyn T, Vanden Bempt I, Meyer-Wentrup FAG, Dors N, van Eijkelenburg NKA, Scheijde-Vermeulen MA, Jazet IM, Limper M, Jak M, Verdijk RM, Donker ML, de Jonge NA, van Noesel CJM, Hebeda KM, van Dorp S, Tonino SH, van Laar JAM, van den Bos C, van Halteren AGS; HOVON Histiocytic and Lymphocytic Diseases Working Group. Kemps PG, et al. Among authors: scheijde vermeulen ma. Blood Neoplasia. 2024 Jun 10;1(3):100023. doi: 10.1016/j.bneo.2024.100023. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453055 Free PMC article.
Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].
Langenberg KPS, Meister MT, Bakhuizen JJ, Boer JM, van Eijkelenburg NKA, Hulleman E, Ilan U, Looze EJ, Dierselhuis MP, Lugt JV, Breunis W, Schild LG, Ober K, van Hooff SR, Scheijde-Vermeulen MA, Hiemcke-Jiwa LS, Flucke UE, Kranendonk MEG, Wesseling P, Sonneveld E, Punt S, Boltjes A, van Dijk F, Verwiel ETP, Volckmann R, Hehir-Kwa JY, Kester LA, Koudijs MMJ, Waanders E, Holstege FCP, Vormoor HJ, Hoving EW, Noesel MMV, Pieters R, Kool M, Stumpf M, Blattner-Johnson M, Balasubramanian GP, Van Tilburg CM, Jones BC, Jones DTW, Witt O, Pfister SM, Jongmans MCJ, Kuiper RP, de Krijger RR, Wijnen MHW, den Boer ML, Zwaan CM, Kemmeren P, Koster J, Tops BBJ, Goemans BF, Molenaar JJ. Langenberg KPS, et al. Among authors: scheijde vermeulen ma. Eur J Cancer. 2025 May 15;221:115423. doi: 10.1016/j.ejca.2025.115423. Epub 2025 Apr 12. Eur J Cancer. 2025. PMID: 40222202 Free PMC article. No abstract available.
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis.
Kemps PG, Woei-A-Jin FJSH, Quint KD, van den Bos C, Naeije L, van Laar JAM, Vanden Bempt I, Koudijs MJ, Vorderman RHP, Stelloo E, Swennenhuis JF, Bruggink AH, Hebeda KM, Scheijde-Vermeulen MA, Diercks GFH, Verdijk RM, Jansen PM, Hauben E, Tousseyn T, Cleven AHG, van Wezel T, van Halteren AGS, Hogendoorn PCW. Kemps PG, et al. Among authors: scheijde vermeulen ma. Blood Adv. 2025 Feb 11;9(3):439-444. doi: 10.1182/bloodadvances.2024013696. Blood Adv. 2025. PMID: 39361730 Free PMC article. No abstract available.
Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue.
Kemps PG, Baelde HJ, Vorderman RHP, Stelloo E, Swennenhuis JF, Szuhai K, Lamers MH, Kenkhuis B, Al-Hussaini M, Briaire-de Bruijn IH, Lam SW, Bovée JVMG, Cleven AHG, Verdijk RM, van Noesel CJM, van Dijk MR, Scheijde-Vermeulen MA, Bruggink AH, van Laar JAM, de Vries ACH, Tissing WJE, van den Bos C, von Deimling A, van Wezel T, van Halteren AGS, Hogendoorn PCW. Kemps PG, et al. Among authors: scheijde vermeulen ma. Blood. 2024 Dec 5;144(23):2439-2455. doi: 10.1182/blood.2024025127. Blood. 2024. PMID: 39316650
Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes.
de Kanter JK, Steemers AS, Gonzalez DM, van Ineveld RL, Blijleven C, Groenen N, Trabut L, Scheijde-Vermeulen MA, Westera L, Beishuizen A, Rios AC, Holstege FCP, Brandsma AM, Margaritis T, van Boxtel R, Meyer-Wentrup F. de Kanter JK, et al. Among authors: scheijde vermeulen ma. Hemasphere. 2024 Sep 2;8(9):e149. doi: 10.1002/hem3.149. eCollection 2024 Sep. Hemasphere. 2024. PMID: 39233904 Free PMC article.
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.
Kroeze E, Kleisman MM, Kester LA, Scheijde-Vermeulen MA, Sonneveld E, Buijs-Gladdines JGC, Hagleitner MM, Meyer-Wentrup FAG, Veening MA, Beishuizen A, Meijerink JPP, Loeffen JLC, Kuiper RP. Kroeze E, et al. Among authors: scheijde vermeulen ma. Hemasphere. 2024 Jun 27;8(7):e117. doi: 10.1002/hem3.117. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38948925 Free PMC article.
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Kroeze E, Iaccarino I, Kleisman MM, Mondal M, Beder T, Khouja M, Höppner MP, Scheijde-Vermeulen MA, Kester LA, Brüggemann M, Baldus CD, Cario G, Bladergroen RS, Garnier N, Attarbaschi A, Verdu-Amorós J, Sutton R, Macintyre E, Scholten K, Arias Padilla L, Burkhardt B, Beishuizen A, den Boer ML, Kuiper RP, Loeffen JLC, Boer JM, Klapper W. Kroeze E, et al. Among authors: scheijde vermeulen ma. Blood. 2024 Jul 4;144(1):74-83. doi: 10.1182/blood.2024023938. Blood. 2024. PMID: 38588489 Free article.
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy.
Wienke J, Visser LL, Kholosy WM, Keller KM, Barisa M, Poon E, Munnings-Tomes S, Himsworth C, Calton E, Rodriguez A, Bernardi R, van den Ham F, van Hooff SR, Matser YAH, Tas ML, Langenberg KPS, Lijnzaad P, Borst AL, Zappa E, Bergsma FJ, Strijker JGM, Verhoeven BM, Mei S, Kramdi A, Restuadi R, Sanchez-Bernabeu A, Cornel AM, Holstege FCP, Gray JC, Tytgat GAM, Scheijde-Vermeulen MA, Wijnen MHWA, Dierselhuis MP, Straathof K, Behjati S, Wu W, Heck AJR, Koster J, Nierkens S, Janoueix-Lerosey I, de Krijger RR, Baryawno N, Chesler L, Anderson J, Caron HN, Margaritis T, van Noesel MM, Molenaar JJ. Wienke J, et al. Among authors: scheijde vermeulen ma. Cancer Cell. 2024 Feb 12;42(2):283-300.e8. doi: 10.1016/j.ccell.2023.12.008. Epub 2024 Jan 4. Cancer Cell. 2024. PMID: 38181797 Free PMC article.
15 results